Concepedia

Tahir Sheikh

TS

Statistics

Publications

9

Citations

583

H-Index

9

Active since

2007

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Columbia University

Tahir Sheikh is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, medicine, and oncology.

Publications per year

2007–2021

9

Publications

9

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh et al. · Clinical Cancer Research · 2007 · 150 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

Samuel McNeely, Chiara Conti, Tahir Sheikh et al. · Cell Cycle · 2010 · 98 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

Martin L. Miller, Evan Molinelli, Jayasree S. Nair et al. · Science Signaling · 2013 · 88 citations

Medicine, Cancer Biology, Oncology +17

Continuous Versus Interrupted Sutures for Primary Cleft Palate Repair

Ghulam Qadir Fayyaz, Nauman Ahmad Gill, Iftikhar Alam et al. · Plastic & Reconstructive Surgery Global Open · 2018 · 69 citations · Full text

Dentistry, Plastic Surgery, Surgery +16

A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

Archie Tse, David S. Klimstra, Mithat Gönen et al. · Clinical Cancer Research · 2008 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 9